Hospital Corporation of China Limited (HKG:3869)
3.400
0.00 (0.00%)
Aug 4, 2026, 9:54 AM HKT
HKG:3869 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 464 | 805 | 931 | 894 | 1,119 | 1,381 | |
Market Cap Growth | -50.51% | -13.50% | 4.09% | -20.10% | -18.92% | -9.35% |
Enterprise Value | 1,004 | 1,379 | 1,636 | 1,470 | 1,856 | 2,482 |
Last Close Price | 3.40 | 5.90 | 6.79 | 6.50 | 8.10 | 9.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.65 | 5.31 | - | 6.18 | - | - |
PS Ratio | 0.28 | 0.49 | 0.61 | 0.57 | 0.87 | 2.16 |
PB Ratio | 0.58 | 1.00 | 1.52 | 1.37 | 2.23 | 0.99 |
P/FCF Ratio | 3.07 | 5.33 | 4.44 | 11.82 | 7.76 | 9.32 |
P/OCF Ratio | 2.64 | 4.58 | 4.13 | 9.67 | 6.92 | 8.45 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.61 | 0.84 | 1.07 | 0.93 | 1.44 | 3.89 |
EV/EBITDA Ratio | 5.01 | 7.08 | 6.50 | 7.11 | 17.20 | 14.85 |
EV/EBIT Ratio | 7.48 | 10.27 | 8.53 | 10.62 | 44.72 | 20.54 |
EV/FCF Ratio | 6.65 | 9.13 | 7.81 | 19.42 | 12.87 | 16.76 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.49 | 1.49 | 2.00 | 1.74 | 2.49 | 0.87 |
Debt / EBITDA Ratio | 5.95 | 5.95 | 4.78 | 5.36 | 11.14 | 7.09 |
Debt / FCF Ratio | 7.89 | 7.89 | 5.85 | 14.98 | 8.65 | 8.18 |
Net Debt / Equity Ratio | 0.37 | 0.37 | 0.59 | 0.61 | 1.07 | 0.18 |
Net Debt / EBITDA Ratio | 1.53 | 1.53 | 1.43 | 1.93 | 4.99 | 1.52 |
Net Debt / FCF Ratio | 1.97 | 1.97 | 1.72 | 5.26 | 3.73 | 1.72 |
Asset Turnover | 0.57 | 0.57 | 0.57 | 0.58 | 0.41 | 0.15 |
Inventory Turnover | 44.93 | 44.93 | 28.26 | 21.91 | 18.88 | 11.21 |
Quick Ratio | 1.59 | 1.59 | 0.59 | 0.54 | 0.43 | 2.13 |
Current Ratio | 1.62 | 1.62 | 0.61 | 0.57 | 0.47 | 2.24 |
Return on Equity (ROE) | 21.43% | 21.43% | 4.51% | 32.54% | -66.94% | -28.96% |
Return on Assets (ROA) | 2.92% | 2.92% | 4.43% | 3.18% | 0.83% | 1.79% |
Return on Invested Capital (ROIC) | 9.10% | 9.45% | 6.89% | 10.45% | 3.25% | 5.71% |
Return on Capital Employed (ROCE) | 6.40% | 6.40% | 23.30% | 15.00% | 5.60% | 3.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 32.71% | 18.85% | -2.98% | 16.18% | -48.57% | -24.96% |
FCF Yield | 32.54% | 18.75% | 22.50% | 8.46% | 12.88% | 10.73% |
Buyback Yield / Dilution | -46.79% | -46.79% | 32.20% | -46.29% | - | - |